These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33673803)
21. Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients. Le Tertre M; Ka C; Guellec J; Gourlaouen I; Férec C; Callebaut I; Le Gac G Transfus Clin Biol; 2017 Nov; 24(4):462-467. PubMed ID: 28826751 [TBL] [Abstract][Full Text] [Related]
23. Transient elevation of serum ferritin in a Sri Lankan with homozygosity for H63D mutation in the HFE gene: a case report. Wickramasinghe W; Karunathilaka C; Jayasinghe S; Gooneratne L J Med Case Rep; 2020 Jul; 14(1):93. PubMed ID: 32641120 [TBL] [Abstract][Full Text] [Related]
24. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis. Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924 [TBL] [Abstract][Full Text] [Related]
25. Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature. Zhang W; Lv T; Huang J; Ou X Medicine (Baltimore); 2017 Sep; 96(38):e8064. PubMed ID: 28930842 [TBL] [Abstract][Full Text] [Related]
26. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403 [TBL] [Abstract][Full Text] [Related]
27. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV. Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113 [TBL] [Abstract][Full Text] [Related]
28. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease. Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317 [TBL] [Abstract][Full Text] [Related]
29. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron. Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219 [TBL] [Abstract][Full Text] [Related]
30. Genetic and clinical heterogeneity of ferroportin disease. Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644 [TBL] [Abstract][Full Text] [Related]
31. [Hereditary hemochromatosis]. Niederau C Med Klin (Munich); 2009 Dec; 104(12):931-46. PubMed ID: 20039160 [TBL] [Abstract][Full Text] [Related]
32. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload. Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368 [TBL] [Abstract][Full Text] [Related]
33. SLC40A1 c.1402G-->a results in aberrant splicing, ferroportin truncation after glycine 330, and an autosomal dominant hemochromatosis phenotype. Lee PL; Gelbart T; West C; Barton JC Acta Haematol; 2007; 118(4):237-41. PubMed ID: 18160816 [TBL] [Abstract][Full Text] [Related]
34. [Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update]. Ruivard M Rev Med Interne; 2009 Jan; 30(1):35-42. PubMed ID: 18584923 [TBL] [Abstract][Full Text] [Related]
35. Inherited Disorders of Iron Overload. Pantopoulos K Front Nutr; 2018; 5():103. PubMed ID: 30420953 [TBL] [Abstract][Full Text] [Related]
36. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Donovan A; Lima CA; Pinkus JL; Pinkus GS; Zon LI; Robine S; Andrews NC Cell Metab; 2005 Mar; 1(3):191-200. PubMed ID: 16054062 [TBL] [Abstract][Full Text] [Related]
37. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin. Pietrangelo A Gastroenterology; 2015 Oct; 149(5):1240-1251.e4. PubMed ID: 26164493 [TBL] [Abstract][Full Text] [Related]
38. Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 disease mutations and identification of critical residues. Le Gac G; Ka C; Joubrel R; Gourlaouen I; Lehn P; Mornon JP; Férec C; Callebaut I Hum Mutat; 2013 Oct; 34(10):1371-80. PubMed ID: 23784628 [TBL] [Abstract][Full Text] [Related]
39. Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man. Del-Castillo-Rueda A; Moreno-Carralero MI; Alvarez-Sala-Walther LA; Cuadrado-Grande N; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ Eur J Haematol; 2011 Mar; 86(3):260-4. PubMed ID: 21175851 [TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of hereditary hemochromatosis. Salgia RJ; Brown K Clin Liver Dis; 2015 Feb; 19(1):187-98. PubMed ID: 25454304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]